Skip to content

IEMbase 0544: MCEE-related methylmalonic aciduria 3

Scope

Field Value
IEMbase ID 544
Nosology 1.2.2.01
Gene MCEE
External IDs OMIM:251120; ORPHA:308425
Generated mapping CANDIDATE; Methylmalonic_Acidemia.yaml
Candidate DisMech targets Broad Methylmalonic_Acidemia.yaml context only
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents MCEE-related methylmalonic aciduria due to methylmalonyl-CoA epimerase deficiency, with alternate labels methylmalonic aciduria 3 and MMAE. The record is autosomal recessive, marked as a benign form, and treatability is unknown. The treatment row lists protein restriction during stress.

The phenotype signal is deliberately sparse: increased urinary methylmalonic acid is the characteristic biochemical row, and the only clinical row states no clinical significance across age periods.

DisMech phenotype coverage

Methylmalonic_Acidemia.yaml provides useful broad context for methylmalonic acid accumulation and propionate-pathway disease, but it does not currently model MCEE, methylmalonyl-CoA epimerase deficiency, or the benign MMAE subtype. The local entry focuses on MMUT and adenosylcobalamin-handling defects such as MMAA and MMAB, with recurrent metabolic decompensation, kidney disease, neurologic injury, cardiomyopathy, C3 propionylcarnitine, methylcitric acid, and crisis-management logic.

That coverage is much more severe and mechanistically different from the IEMbase MCEE record.

Concordance and completeness

Judgement: partial broad context only; do not treat the generated candidate as an exact MCEE mapping.

IEMbase and DisMech overlap on methylmalonic acid elevation, but IEMbase is a gene-specific, benign epimerase-deficiency record. The current local MMA entry does not include the MCEE mechanism or the low-clinical-significance scope.

Curation actions

  • Do not collapse this record into the existing MMA entry as an exact match.
  • If MCEE is in scope, add a methylmalonic aciduria 3 / MMAE subtype or a small standalone MCEE target under methylmalonic acidemia context.
  • Preserve urinary methylmalonic acid, benign/no-clinical-significance wording, autosomal recessive inheritance, and stress protein-restriction as prompts.